Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
Keyword(s):
2013 ◽
Vol 72
(Suppl 3)
◽
pp. A306.2-A306
Keyword(s):
2021 ◽
Vol 77
(18)
◽
pp. 441
2014 ◽
Vol 25
(7)
◽
pp. 1945-1951
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 149
(4)
◽
pp. 971-980.e1
◽
Keyword(s):
2018 ◽
Vol 45
(5)
◽
pp. 529-539
◽